Cargando…

Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma

While melanoma remains a challenge for oncologists, possibilities are being continuously explored to fight resistant metastatic melanoma more effectively. Eugenol is reported to inhibit survivin protein in breast cancer cells. Survivin is also overexpressed by melanoma cells, and is known to impart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mishra, Harshita, Mishra, Pawan Kumar, Iqbal, Zeenat, Jaggi, Manu, Madaan, Alka, Bhuyan, Kimi, Gupta, Namita, Gupta, Neha, Vats, Karnika, Verma, Ritu, Talegaonkar, Sushama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523131/ https://www.ncbi.nlm.nih.gov/pubmed/30987266 http://dx.doi.org/10.3390/pharmaceutics11040163

Ejemplares similares

Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery
por: Bhandari, Jyoti, et al.
Publicado: (2017)

Wood-Based Cellulose Nanofibrils: Haemocompatibility and Impact on the Development and Behaviour of Drosophila melanogaster
por: Mishra, Pawan Kumar, et al.
Publicado: (2019)

Treatment modalities and evaluation models for periodontitis
por: Tariq, Mohammad, et al.
Publicado: (2012)

Liquid Chromatographic Method for Irinotecan Estimation: Screening of P-gp Modulators
por: Tariq, M., et al.
Publicado: (2015)

Data of aromatase inhibitors alone and in combination with raloxifene on microarchitecture of lumbar vertebrae and strength test in femoral diaphysis of VCD treated ovotoxic mice
por: Kalam, Abul, et al.
Publicado: (2016)

Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation
por: Al-Sharif, Ibtehaj, et al.
Publicado: (2013)

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
por: Jiang, Guan, et al.
Publicado: (2014)

Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma
por: Xin, Yong, et al.
Publicado: (2016)

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
por: Middleton, M R, et al.
Publicado: (2000)

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma
por: Daponte, Antonio, et al.
Publicado: (2013)

Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
por: Wadhwa, Ravisha, et al.
Publicado: (2017)

Nanocrystalization: An Emerging Technology to Enhance the  Bioavailability of Poorly Soluble Drugs
por: Joshi, Kavita, et al.
Publicado: (2019)

Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma
por: Sherrill, B, et al.
Publicado: (2013)

Design and in vitro/in vivo evaluations of a multiple-drug-containing gingiva disc for periodontotherapy
por: Jain, Pooja, et al.
Publicado: (2020)

HEPATOTOXICITY OF EUGENOL
por: Soundran, Vijaya, et al.
Publicado: (1994)

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
por: Pectasides, D., et al.
Publicado: (1989)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Dacarbazine mediates antimelanoma effects via NK cells
por: Hervieu, Alice, et al.
Publicado: (2013)

Evaluation of protective effect of amifostine on dacarbazine induced genotoxicity
por: Etebari, M., et al.
Publicado: (2015)

Dacarbazine nanoparticle topical delivery system for the treatment of melanoma
por: Hafeez, Abdul, et al.
Publicado: (2017)

Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma
por: Couronne, Thomas, et al.
Publicado: (2020)

Dacarbazine/doxorubicin/vinblastine: Lack of efficacy: case report
Publicado: (2022)

An In vitro Study to Evaluate the Effect of Eugenol-free and Eugenol-containing Temporary Cements on the Bond Strength of Resin Cement and Considering Time as a Factor
por: Chiluka, Lavanya, et al.
Publicado: (2017)

Nanocellulose-Based Biomedical Scaffolds in Future Bioeconomy: A Techno-Legal Assessment of the State-of-the-Art
por: Mishra, Pawan Kumar, et al.
Publicado: (2022)

Synthesis of Isomers of Eugenol
por: Brauer, Gerhard M., et al.
Publicado: (1963)

Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994)

Synthesis and Molecular-cellular Mechanistic Study of Pyridine Derivative of Dacarbazine
por: Amirmostofian, Marzieh, et al.
Publicado: (2013)

Dacarbazine depletes the ovarian reserve in mice and depletion is enhanced with age
por: Winship, Amy L., et al.
Publicado: (2018)

Synthesis, Spectroscopic, and Theoretical Study of Copper and Cobalt Complexes with Dacarbazine
por: Świderski, Grzegorz, et al.
Publicado: (2021)

Enhancement of the antioxidant and skin permeation properties of eugenol by the esterification of eugenol to new derivatives
por: Makuch, Edyta, et al.
Publicado: (2020)

Nanotechnology in Cosmetics and Cosmeceuticals—A Review of Latest Advancements
por: Gupta, Vaibhav, et al.
Publicado: (2022)

Optimization and Designing of Amikacin-loaded Poly D, L-Lactide-co-glycolide Nanoparticles for Effective and Sustained Drug Delivery
por: Fatima, Saman, et al.
Publicado: (2019)

A Review of Adsorbents for Heavy Metal Decontamination: Growing Approach to Wastewater Treatment
por: Gupta, Archana, et al.
Publicado: (2021)

Survivin: a unique target for tumor therapy
por: Garg, Himani, et al.
Publicado: (2016)

Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1994)

Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
por: Lee, S. M., et al.
Publicado: (1993)

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma
por: Long, Georgina V, et al.
Publicado: (2015)

Pre-treatment With PLGA/Silibinin Nanoparticles Mitigates Dacarbazine-Induced Hepatotoxicity
por: Durymanov, Mikhail, et al.
Publicado: (2020)

Synergistic inhibitory effects of the oxyresveratrol and dacarbazine combination against melanoma cells
por: Lee, Sang Gyu, et al.
Publicado: (2021)

Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy
por: Xiong, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jgtb74lr524hahs32s4ktgfbgr